Alkem Laboratories on Thursday posted an 11 % increase in consolidated net profit at ₹ 779 crore during the September quarter.
The company reported a net profit of ₹ 702 crore in the July-September period of the last fiscal year.
Revenue from operations increased to ₹ 4,001 crore for the second quarter of the ongoing fiscal year as against ₹ 3,415 crore in the year-ago period, Alkem Laboratories said in a regulatory filing.
1 December 2025
Get the latest issue of Outlook Business
Growth in the second quarter was marked by robust growth across India, the US, and key international markets, the company stated.
Shares of the drug firm ended 0.87 % down at ₹ 5,715 apiece on the BSE.
